11:43 NFE NEW FORTRESS ENERGY Recapitalizes With 1-for-50 Reverse Split An amended charter effective September 11, 2026 combines every 50 Class A shares into one, wipes out Class B stock and creates mandatorily convertible preferred. Regulatory Sep 11 a day ago PRO 08:04 KPTI KARYOPHARM Strikes Forbearance Deal With Lenders and Noteholders Karyopharm signed a forbearance agreement and limited waiver covering its term loan, both 9.00% convertible note series and its royalty financing. Regulatory Sep 11 a day ago PRO 06:13 CNI CN Files Midwest Access Conditions in UNION PACIFIC-Norfolk Southern Merger Review CN told the Surface Transportation Board it will seek trackage rights and yard access in Kansas City, St. Louis and Illinois as a merger remedy. Regulatory Sep 11 a day ago PRO 08:45 WRD WERIDE Wins Spain's First National Permit for Level 4 Robotaxis WeRide, Uber and fleet operator AVOMO received Spain's first national Level 4 autonomous passenger vehicle permit, targeting a commercial Madrid launch by end-2026. Regulatory Sep 10 2 days ago PRO 06:25 WRD WERIDE and Uber Win Spain's First National Level 4 Robotaxi Permit Spain's traffic authority cleared WeRide, Uber and fleet operator AVOMO to prepare a driverless service in Madrid, with commercial rides targeted by end-2026. Regulatory Sep 10 2 days ago PRO 09:04 INBS INTELLIGENT BIO SOLUTIONS Files FDA 510(k) for Fingerprint Drug Test INBS submitted its 510(k) premarket notification for codeine detection with its fingerprint sweat screening system, backed by studies showing 100% specificity. Regulatory Sep 9 3 days ago PRO 08:36 IVDA IVEDA Wins Second 180-Day Nasdaq Extension on $1 Bid Price Iveda has until March 1, 2027 to close above $1.00 for ten straight sessions and says a reverse split remains one option. Regulatory Sep 9 3 days ago PRO 07:59 QBTS D-WAVE QUANTUM Hands US Commerce Department an Equity Stake for CHIPS Award D-Wave agreed to issue common stock to the US Department of Commerce at $14.093 per share as an inducement for a CHIPS Act award signed on September 4, 2026. Regulatory Sep 9 3 days ago PRO 16:02 QNRX FDA Grants QUOIN PHARMACEUTICALS Second Rare Pediatric Tag for QRX003 Quoin's lead asset QRX003 receives Rare Pediatric Disease Designation for Peeling Skin Syndrome, opening the door to a second Priority Review Voucher. Regulatory Sep 8 4 days ago PRO 13:52 ABAT AMERICAN BATTERY TECHNOLOGY Clears BLM Hurdle for Tonopah Flats Lithium The Bureau of Land Management accepted the mine and refinery Plan of Operations for ABTC's Nevada lithium project, moving it into environmental review. Regulatory Sep 8 4 days ago PRO 13:52 GFS GLOBALFOUNDRIES to Issue 9.9M Shares to U.S. Commerce Department GlobalFoundries will hand the Commerce Department nearly 9.91 million ordinary shares at $37.85 apiece, a stake worth roughly $375 million. Regulatory Sep 8 4 days ago PRO 13:52 DFTX FDA Grants DEFINIUM Second Breakthrough Therapy Tag for LSD Tablet Definium's DT120 gets Breakthrough Therapy designation in major depressive disorder after a Phase 3 win, adding to an earlier tag in generalized anxiety. Regulatory Sep 8 4 days ago PRO 07:35 AZN FDA Approves ASTRAZENECA Breast Cancer Drug Etcamah for First-Line Use Accelerated US approval of camizestrant with a CDK4/6 inhibitor rests on SERENA-6, which cut the risk of progression or death by 56%. Regulatory Sep 8 4 days ago PRO 07:35 QBTS D-WAVE Signs $100M CHIPS Act Award With Commerce Department D-Wave Quantum has entered a $100 million Other Transaction Agreement with the U.S. Department of Commerce to prototype scalable superconducting quantum components. Regulatory Sep 8 4 days ago PRO 07:03 POMRY POMMERY Auditors Flag Material Going-Concern Doubt in 2025 Filing The Champagne group's 2025 registration document carries an auditor paragraph on material uncertainty over its ability to continue as a going concern. Regulatory Sep 8 4 days ago PRO 14:05 Regulatory PHARMA EQUITY GROUP Faces Court Challenge to EUR 10.5M Arbitral Award Interpatium has asked a Danish district court to set aside the June 2026 arbitration ruling that ordered it to pay Pharma Equity Group EUR 10.5 million. Sep 7 5 days ago PRO 10:53 GURE GULF RESOURCES Files 8-K on Nasdaq Listing Deficiency The Shandong-based chemicals producer disclosed an Item 3.01 notice covering delisting or failure to satisfy a continued listing rule. Regulatory Sep 4 8 days ago PRO 10:53 QNCX QUINCE THERAPEUTICS Files 8-K Flagging Listing Rule Issue The biotech filed an Item 3.01 disclosure with the SEC covering a delisting notice or failure to meet a continued listing standard, dated August 31, 2026. Regulatory Sep 4 8 days ago PRO 10:52 SNTI SENTI BIOSCIENCES Files Amended Terms for Senior Secured Convertible Notes An 8-K discloses a revised form of senior secured convertible note maturing November 23, 2026, repayable in cash at 200% of outstanding principal. Regulatory Sep 4 8 days ago PRO 10:52 DPU TOP KINGWIN Holders Approve 1-for-50 Reverse Split and Nexpu Name Change Shareholders backed a 200x supervoting Class B structure, a jump in authorized capital to $625 million and a share consolidation effective December 17, 2026. Regulatory Sep 4 8 days ago PRO 10:40 IONS FDA Approves IONIS Drug Zanvastro for Alexander Disease Ionis wins first-ever approval for a disease-modifying Alexander disease therapy, plus a rare pediatric disease priority review voucher. Regulatory Sep 4 8 days ago PRO 10:31 NLST NETLIST Loses Three Federal Circuit Appeals Against Micron on Same Day The Federal Circuit affirmed PTAB rulings invalidating claims of five Netlist memory patents challenged by Micron, including one precedential decision. Regulatory Sep 3 9 days ago PRO 04:42 AUGO Aura Minerals Director Sells $10.4 Million of Shares in Open Market A Form 4 shows director Bruno Sousa Mauad sold 127,500 Aura Minerals shares at $81.20 apiece on Aug. 31, cutting his stake by more than 40%. Regulatory Sep 3 10 days ago PRO 15:53 ABT FDA Authorizes First Dual Glucose and Ketone Wearable, Abbott's Libre Duo The FDA cleared the Libre Duo 10 Day Continuous Dual Glucose Ketone Monitoring System for people with diabetes aged 2 and older. Regulatory Sep 2 10 days ago PRO 15:53 RVMD FDA Approves Rasonque, First RAS Inhibitor for Metastatic Pancreatic Cancer The FDA cleared daraxonrasib for the most common form of advanced pancreatic cancer, acting months ahead of its review deadline. Regulatory Sep 2 10 days ago PRO 15:53 ROIV FDA Approves Lisraya, First Oral Drug for Dermatomyositis in Adults The FDA has cleared Lisraya (brepocitinib) tablets, the first oral therapy specifically indicated for adults with dermatomyositis. Regulatory Sep 2 10 days ago PRO 15:53 PTGX FDA Approves Mimrylo (Rusfertide), First Hepcidin Mimetic for Polycythemia Vera The FDA has cleared Mimrylo (rusfertide) for adults with polycythemia vera, calling it the first drug of its kind for the rare blood disorder. Regulatory Sep 2 10 days ago PRO 13:08 BRLS Borealis Foods Gets Nasdaq Deficiency Notice Over Late Q2 10-Q Borealis Foods says a review of the accounting treatment of its Conversion Agreement delayed its second-quarter report, triggering a Nasdaq compliance notice. Regulatory Sep 2 10 days ago PRO